Company / Financials
VACCINEX, INC. Financials
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$601.0K
FY2024 · +5.4% YoY
Net Income
-$18.6M
FY2024 · +8.0% YoY
Profit Margin
-3100.5%
FY2024 · net income / revenue
ROE
-
FY2024 · return on equity
Total Assets
$2.6M
FY2024
Total Debt
$0
0.00x debt/equity
Equity
-$2.5M
FY2024
ROA
-717.8%
FY2024 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -140.09 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$601.0K+5.4% YoYNet Income HistoryProfit after all expenses and taxes-$18.6M+8.0% YoYCost of Revenue HistoryDirect costs of producing goods and services sold-Operating Income HistoryProfit from core business operations before interest and taxes-$18.7M+18.1% YoYSG&A Expense HistorySelling, general, and administrative expenses$6.8M-1.3% YoYR&D Expense HistoryResearch and development spending$12.5M-24.3% YoYInterest Expense HistoryCost of borrowing and debt obligations$2.0K+100.0% YoYIncome Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$43.68+55.5% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$43.68+55.5% YoY